IBM
Same song, slightly louder
Evercore ISI is back on the IBM bull train, reiterating an Outperform rating and a $345 price target on the stock. In analyst-speak, that’s the equivalent of saying, “No need to panic, this thing still has room to run.”
Why this matters
IBM has been living in that awkward middle zone where it’s not the flashy new kid and not exactly a sleepy legacy relic either. It’s trying to sell investors on a steady mix of software, consulting, and AI upside — and the market keeps asking, “Cool, but does it actually grow?”
Having Evercore stick with a higher target matters because IBM is heading into its Q1 2026 earnings report on April 22. That means the stock is getting its pre-earnings beauty pageant moment, with analysts lining up to either fan the flames or throw a little cold water on valuation.
The analyst pileup is getting crowded
This isn’t just one firm making noise. Recent notes from other banks have already trimmed targets or changed tone, which tells you Wall Street is still debating how much premium IBM deserves.
- RBC Capital cut its target to $330
- Oppenheimer set $320
- Bernstein SocGen lowered to $280
- BofA Securities landed at $300
So yes, the room is split. But Evercore’s call says the bullish case isn’t dead — it’s just waiting for IBM to prove the numbers still match the narrative.
Big picture
For investors, this is less about one analyst having a hot take and more about the vibe check around IBM ahead of earnings. If the company can show the AI and enterprise story is translating into real growth, that $345 target starts looking less like fantasy and more like a dare.